Andrew Weinberg
Company: AgonOx
Job title: President & Chief Scientific Officer
Seminars:
Unveiling Novel Approaches to Expanding Tumor- Reactive T-Cells & Reducing Bystander T-Cells 2:00 pm
Sorting CD8 TIL for CD39 and CD103 prior to expansion enhances for tumor reactivity This selected expanded TIL has clinical activity in late-stage cancer patientsRead more
day: Conference Day One - Track B - PM